Double blind randomized phase IV clinical trial to evaluate the efficacy of fluvastatin on inflammatory markers in the haemodynamic progression of degenerative aortic stenosis. The AORTICA 1 study.

Trial Profile

Double blind randomized phase IV clinical trial to evaluate the efficacy of fluvastatin on inflammatory markers in the haemodynamic progression of degenerative aortic stenosis. The AORTICA 1 study.

Suspended
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2014

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Aortic valve stenosis
  • Focus Biomarker; Therapeutic Use
  • Acronyms AORTICA-1
  • Most Recent Events

    • 03 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top